Can Radiation Therapy Cause Bleeding?

Radiation therapy can cause bleeding in several parts of the body, and it is one of the more common and sometimes serious side effects of treatment. The bleeding may show up during or shortly after a course of radiation, or it may not appear until months or even years later. Where it occurs depends largely on which part of the body was irradiated: pelvic radiation can lead to rectal or bladder bleeding, chest radiation can trigger coughing up blood, and head and neck radiation carries the risk of severe vascular events. Understanding how and why this happens, and what can be done about it, matters for anyone undergoing or considering radiation treatment.

How Radiation Damages Blood Vessels and Tissue

Radiation kills cancer cells by damaging their DNA, but it inevitably hits healthy tissue in the process. One of the most vulnerable targets is the lining of blood vessels. Radiation injures the endothelial cells that form the inner wall of arteries and veins, and this damage sets off a chain of events that can weaken vessels, promote scarring, and reduce blood flow to surrounding tissue.¹ Over time, the affected tissue becomes fragile, poorly oxygenated, and prone to spontaneous bleeding.

Radiation also triggers a wave of inflammatory signals in normal tissue. One of these, a molecule called TGF-β, has been linked to tissue toxicity in the lungs, intestines, and bone marrow after conventional radiation.² This inflammatory response is part of why radiation side effects sometimes worsen over time rather than fading. The initial injury heals incompletely, scar tissue replaces healthy tissue, and the area becomes more vulnerable to breakdown and bleeding with each passing year.

Rectal Bleeding After Pelvic Radiation

Radiation proctitis, or inflammation and damage to the rectum, is the most commonly discussed form of radiation-induced bleeding. It is a well-recognized complication of radiation therapy for pelvic cancers, including prostate, cervical, rectal, and bladder cancers.³ The rectum sits close to these organs, so it frequently absorbs a significant dose of radiation even when it is not the intended target.

In its acute form, radiation proctitis can cause diarrhea, urgency, and mild rectal bleeding during treatment or in the weeks that follow. These symptoms usually improve on their own. The chronic form is more concerning. It develops months to years after treatment, when the blood vessels in the rectal wall have been permanently altered. These fragile, abnormal vessels bleed easily, sometimes on a daily basis. The bleeding ranges from minor spotting to severe hemorrhage that requires transfusion. Ionizing radiation damages the rectal lining directly, and the chronic changes that follow make the tissue prone to ongoing injury.⁴

Bladder Bleeding

Hemorrhagic cystitis, or bleeding from the bladder lining, is a rarer but potentially severe consequence of pelvic radiation. Like rectal bleeding, it stems from the same process of vascular damage and tissue fragility, but in the bladder wall instead.⁵ Patients may notice blood in the urine ranging from a faint pink tint to heavy, clot-forming hemorrhage that can obstruct urine flow and require emergency intervention.

Pinning down exactly how often severe bladder bleeding happens has been difficult, but most studies put the incidence of serious blood in the urine after pelvic radiation at under 5%. The risk increases with time since treatment, which reflects the progressive nature of radiation-induced vascular damage.⁶ A patient who finishes pelvic radiation without bladder symptoms is not necessarily in the clear years later.

Bleeding in the Head and Neck

Some of the most dramatic radiation-related bleeding events involve the head and neck, particularly the carotid arteries. Carotid blowout syndrome occurs when radiation weakens the wall of a carotid artery to the point of rupture. It is rare, but it can be life-threatening.⁷ The risk rises substantially when patients undergo a second course of radiation to a previously irradiated area, a scenario that comes up when head and neck cancers recur.⁸

Because the carotid arteries supply blood to the brain, a blowout can present as sudden massive bleeding from the mouth, nose, or through the skin of the neck. Patients who have had surgery and radiation to the neck may have exposed or poorly covered vessels, making them especially vulnerable. This is one reason why radiation oncologists carefully weigh the risks and benefits of re-irradiation in previously treated head and neck cancer patients.

Coughing Up Blood After Chest Radiation

Patients who receive radiation for lung cancer can develop fatal hemoptysis, or life-threatening bleeding from the airways. In a study of 150 patients with non-small cell lung cancer treated with combined chemotherapy and radiation, 8% died from fatal hemoptysis.⁹ Nearly all of those cases involved tumors located centrally in the chest, and all patients had signs of radiation-related lung injury such as radiation pneumonitis or fibrosis before the fatal bleeding event.

Central tumors are particularly risky because they sit near large blood vessels and major airways. When radiation damages those structures and the tumor erodes into a vessel wall, the resulting bleed can be sudden and overwhelming. Warning signs in the days and weeks before a fatal event included fever related to infection, worsening shortness of breath, and chest pain. This makes it important for patients and their care teams to monitor respiratory symptoms closely in the months after chest radiation.

Brain Bleeding Years After Treatment

One of the less well-known consequences of radiation therapy is the formation of cavernous malformations in the brain. These are clusters of abnormal, thin-walled blood vessels that can develop in previously irradiated brain tissue. They are most strongly associated with radiation received during childhood, and they can take many years to appear. In one review of cases, cavernomas developed anywhere from 3 to 41 years after childhood radiation treatment.¹⁰

A larger study identified 32 patients with radiation-induced cavernous malformations and found that these abnormal vessel clusters always formed within the area that had been irradiated. The median time from radiation to diagnosis was 12 years. About 44% of patients experienced symptomatic bleeding in the brain at some point.¹¹ This means that childhood cancer survivors who received brain radiation may need long-term monitoring for vascular abnormalities that do not show up for a decade or more. A hemorrhagic brain lesion in a patient with a history of cranial radiation should prompt consideration of a radiation-induced cavernoma.

The interval between radiation and hemorrhage in cases of brain tissue necrosis can be even longer. In a series of patients who developed acute hemorrhage in areas of radiation-damaged brain tissue, the average time from radiation to bleeding was nearly 8 years.¹²

When Radiation Lowers Platelet Counts

Radiation does not only damage blood vessels at the treatment site. When it reaches the bone marrow, it can suppress the production of platelets, the blood cells responsible for clotting. This drop in platelet count, called thrombocytopenia, can cause widespread bleeding that is not localized to the radiation field. Bleeding from low platelets can show up as easy bruising, nosebleeds, bleeding gums, or more serious internal hemorrhage. In patients receiving radiation therapy, thrombocytopenia can be severe enough to delay treatment and require transfusions of both platelets and red blood cells.¹³

The risk of clinically significant thrombocytopenia depends on how much bone marrow falls within the radiation field. Pelvic radiation, for instance, irradiates a large volume of marrow-rich bone and carries a higher risk than treatment directed at a small peripheral site. Patients receiving concurrent chemotherapy, which independently suppresses marrow, face a compounded risk.

What Raises the Risk of Radiation-Induced Bleeding

Not everyone who receives radiation therapy develops significant bleeding. Several factors push the risk higher. One of the most clearly demonstrated is the use of blood-thinning medications. In a study of 855 prostate cancer patients, the only factor that significantly predicted late gastrointestinal toxicity of moderate severity or worse was anticoagulation with warfarin or clopidogrel. Radiation dose, field size, and the use of seed implants were not significant predictors by comparison.¹⁴ This finding has practical implications: patients on blood thinners should discuss the interaction with their radiation oncologist, and in some cases, the anticoagulation regimen may need to be adjusted during and after treatment.

Radiation dose to nearby organs also plays a role, though it may be harder for patients to control. In an analysis of radiation-induced stomach bleeding, the median maximum dose delivered to the stomach was around 61 Gy after adjusting for standard fractionation.¹⁵ Treatment planning tries to minimize dose to sensitive structures, but when a tumor sits near the stomach, bowel, or bladder, some exposure to those organs is unavoidable. Modern techniques like intensity-modulated radiation therapy help shape the radiation beam more precisely, but they cannot eliminate the risk entirely.

Other factors that can increase bleeding risk include a history of prior radiation to the same area (re-irradiation), surgical disruption of local blood supply, concurrent chemotherapy, and pre-existing conditions that affect vascular health such as diabetes or atherosclerosis.

How Radiation-Induced Bleeding Is Treated

The approach to treatment depends on where the bleeding is occurring and how severe it is. For rectal bleeding from radiation proctitis, one of the most effective options is argon plasma coagulation, an endoscopic technique that uses a jet of ionized gas to cauterize bleeding vessels. In a randomized trial comparing argon plasma coagulation to topical formalin, the bleeding stopped in 94% of patients treated with argon plasma and 100% of those treated with formalin, typically after just two sessions. After follow-up stretching beyond nine years, only one patient in each group required additional treatment.¹⁶ An earlier study of 40 patients also found that argon plasma coagulation was successful in all but one case, and that patient responded to formalin treatment instead.¹⁷

Hyperbaric oxygen therapy is another option, particularly for bladder bleeding. By exposing the patient to pure oxygen at higher-than-normal atmospheric pressure, the treatment promotes new blood vessel growth and tissue healing in radiation-damaged areas. In a small series, complete resolution of blood in the urine was seen in about 81% of patients treated with hyperbaric oxygen, though bleeding recurred in roughly a third of them within about 10 months.¹⁸ For rectal bleeding, the results were more mixed in the same study, with complete resolution in half of treated patients. Hyperbaric oxygen requires many sessions over several weeks, which can be a logistical burden, but it addresses the underlying tissue damage rather than just cauterizing individual bleeding points.

When bleeding proves stubborn and does not respond to endoscopic treatments, interventional radiology offers a more aggressive option. Superselective arterial embolization involves threading a catheter through the blood vessels and blocking the specific arteries feeding the bleeding site. This technique has been used successfully for both bladder bleeding and stomach bleeding that could not be controlled with standard methods.^{19 20} It is generally reserved for cases where surgery is not feasible or less invasive treatments have failed.

Drug-based approaches have been less convincing. A small trial of pentoxifylline, a medication that improves blood flow through small vessels, could not demonstrate a clear benefit for radiation-induced rectal bleeding compared to standard care, though a modest effect could not be ruled out.²¹ Researchers have suggested that larger trials with longer treatment durations might be needed to settle the question, but for now, procedural interventions remain the mainstay.

Timing Matters More Than You Might Expect

One of the most unsettling aspects of radiation-induced bleeding is how unpredictable its timing can be. Acute radiation effects, including mild bleeding, typically occur during treatment or within the first few weeks after it ends. These usually resolve as the tissue heals. But the late effects, which are often more serious, follow a completely different timeline.

Chronic rectal and bladder bleeding tends to emerge between six months and several years after treatment. Carotid artery complications can appear years later. Brain cavernomas, as noted earlier, have been diagnosed as late as four decades after childhood radiation. This long latency period means that patients and their doctors need to maintain awareness of radiation history over a lifetime. A patient who develops unexplained bleeding in a body region that was previously irradiated, even decades ago, should consider radiation injury as a possible cause. Many of these late effects are progressive, meaning they worsen over time rather than plateau.

Newer Radiation Techniques and Bleeding Risk

Advances in radiation delivery have reduced, though not eliminated, the risk of bleeding complications. Techniques like intensity-modulated radiation therapy and stereotactic body radiation therapy allow clinicians to deliver high doses to tumors while limiting exposure to surrounding healthy tissue. Proton therapy, which deposits most of its energy at a specific depth and largely spares tissue beyond the target, has also drawn interest for its potential to reduce late toxicity. In comparisons for bilateral breast cancer treatment, proton therapy was associated with lower estimated risks of secondary cancers and cardiac events than conventional photon radiation, though it produced more skin reactions.²²

These newer approaches are not a blanket solution to radiation-induced bleeding. They reduce the volume of normal tissue exposed, but the tissue that does receive radiation is still subject to the same biological cascade of vascular injury and inflammation. In situations where the tumor abuts a critical organ, some exposure to that organ is unavoidable regardless of technique. Spacer devices, such as hydrogel placed between the prostate and rectum during prostate radiation, represent another strategy for physically moving sensitive tissue out of the high-dose zone. Each of these tools shaves down the probability of bleeding complications, but none of them eliminates it.

When to Talk to Your Doctor

If you are currently receiving or have previously received radiation therapy, any new or worsening bleeding warrants a conversation with your care team. Rectal bleeding, blood in the urine, coughing up blood, or unusual bruising and nosebleeds can all be related to radiation. The connection is not always obvious, especially if the treatment was years ago. Being upfront about your full treatment history, including radiation fields, total dose, and whether you had concurrent chemotherapy, helps your doctors evaluate bleeding symptoms in the right context.

Patients on blood-thinning medications deserve particular attention. As the prostate cancer study demonstrated, anticoagulation was a stronger predictor of late gastrointestinal toxicity than the radiation dose itself. If you are taking a blood thinner and planning to undergo pelvic radiation, discuss the interaction explicitly. In some cases, switching to a different anticoagulant, adjusting the dose, or timing the medications differently may reduce your risk without compromising the reason you are on the blood thinner in the first place.